KPIs & Operating Metrics(New)
Balance Sheet
Cash Flow Statement
Capital ExpendituresCapital ExpendituresCash from Financing ActivitiesCash from Financing ActivitiesCash from Investing ActivitiesCash from Investing ActivitiesCash from OperationsCash from OperationsChange in Account PayablesChange in Account PayablesChange in Acquisitions & DivestmentsChange in Acquisitions & DivestmentsChange in CashChange in ReceivablesChange in ReceivablesExchange Rate EffectExchange Rate EffectFree Cash FlowFree Cash FlowGains from Investment SecuritiesGains from Investment SecuritiesLong-Term Debt RepaymentsNet Cash FlowNet Cash FlowNet IncomeSales of Property, Plant and EquipmentSales of Property, Plant and EquipmentShare-based CompensationShare-based CompensationShares IssuedShares Repurchased
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Bio-Rad Laboratories (BIO) Gains from Investment Securities (2016 - 2025)

Bio-Rad Laboratories (BIO) has disclosed Gains from Investment Securities for 16 consecutive years, with $78.4 million as the latest value for Q4 2025.

  • Quarterly Gains from Investment Securities rose 223.08% to $78.4 million in Q4 2025 from the year-ago period, while the trailing twelve-month figure was $81.0 million through Dec 2025, up 2282.35% year-over-year, with the annual reading at $81.0 million for FY2025, 2282.35% up from the prior year.
  • Gains from Investment Securities for Q4 2025 was $78.4 million at Bio-Rad Laboratories, up from $2.5 million in the prior quarter.
  • The five-year high for Gains from Investment Securities was $78.4 million in Q4 2025, with the low at -$72.3 million in Q3 2022.
  • Average Gains from Investment Securities over 5 years is $5.7 million, with a median of $7.3 million recorded in 2023.
  • The sharpest move saw Gains from Investment Securities soared 3918.29% in 2021, then plummeted 1432.08% in 2024.
  • Over 5 years, Gains from Investment Securities stood at -$22.3 million in 2021, then surged by 100.56% to $124000.0 in 2022, then skyrocketed by 3756.45% to $4.8 million in 2023, then tumbled by 1432.08% to -$63.7 million in 2024, then skyrocketed by 223.08% to $78.4 million in 2025.
  • According to Business Quant data, Gains from Investment Securities over the past three periods came in at $78.4 million, $2.5 million, and -$16.2 million for Q4 2025, Q3 2025, and Q2 2025 respectively.